{
  "meta": {
    "title": "00209_Late_Night_Pyqs_Mixed_Bag-30",
    "url": "https://brainandscalpel.vercel.app/00209-late-night-pyqs-mixed-bag-30-c2f9c42e.html",
    "scrapedAt": "2025-11-29T17:27:34.450Z"
  },
  "questions": [
    {
      "id": 16084,
      "choices": [
        {
          "id": 64296,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 64297,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4, 1</span></p>"
        },
        {
          "id": 64298,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4, 1, 2</span></p>"
        },
        {
          "id": 64299,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 3, 2, 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange lung hilar structures from anterior to posterior:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Primary bronchus</span></p><p><span style=\"font-size:12.0pt;\">2. Bronchial artery</span></p><p><span style=\"font-size:12.0pt;\">3. Pulmonary vein</span></p><p><span style=\"font-size:12.0pt;\">4. Pulmonary artery</span></p>",
      "unique_key": "Q4167339",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269483,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 3, 4, 1, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lung hilar structures are arranged from the anterior to posterior in the order:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pulmonary vein</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary artery</span></li><li><span style=\"font-size:12.0pt;\">Primary bronchus</span></li><li><span style=\"font-size:12.0pt;\">Bronchial artery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The superior vena cava and right atrium are seen in front of the right root and terminal part of the azygos vein superiorly. The hilar structures are arranged from the superior to inferior as:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Superior lobar bronchus</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary artery</span></li><li><span style=\"font-size:12.0pt;\">Principal bronchus</span></li><li><span style=\"font-size:12.0pt;\">Inferior pulmonary vein</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/3_jLth6bh.jpg\" width=\"2040\" height=\"699\"></p>",
      "correct_choice_id": 64298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6973,
      "choices": [
        {
          "id": 27860,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
        },
        {
          "id": 27861,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Methotrexate</span></p>"
        },
        {
          "id": 27862,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿﻿﻿﻿Vinblastine</span></p>"
        },
        {
          "id": 27863,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿﻿﻿﻿Vincristine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A boy presents with pallor and lymphadenopathy; the X-ray of his skull is given below. Which of the following drug is not used for the management of the suspected diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/picture4_YOReme1.jpg\" alt=\"\" width=\"300\" height=\"286\"></span></p>",
      "unique_key": "Q7215210",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269491,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Vincristine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The X-ray of the skull is showing circumscribed punched out lesions in the skull of a boy whose history reveals the presence of pallor and lymphadenopathy. This is suggestive of Langerhans Cell Histiocytosis.</span></li><li><span style=\"font-size:12pt;\">Langerhans cell histiocytosis (LCH) is a rare disease in which an excess of immature Langerhans cells (a type of white blood cell) accumulates in various parts of the body, leading to tissue damage and dysfunction.</span></li><li><span style=\"font-size:12pt;\">The treatment of LCH depends on the severity and extent of the disease, as well as the age and overall health of the patient. Some cases of LCH can go away on their own, while others require treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>The main treatment options for LCH include:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">1. Observation: In some cases, particularly in mild cases that only involve one or a few areas of the body, doctors may recommend monitoring the disease closely without any treatment. The goal is to watch for any changes or progression of the disease and intervene if necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">2. Chemotherapy: Chemotherapy drugs are used to kill the abnormal Langerhans cells and control the disease. Some commonly used chemotherapy drugs for LCH include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Vinblastine</strong>: Vinblastine is a chemotherapy drug that is often used as the first-line treatment for LCH, particularly in children. It works by disrupting the growth of abnormal Langerhans cells. Vincristine is not recommended for LCH.</span></li><li><span style=\"font-size:12pt;\"><strong>Methotrexate</strong>: Methotrexate is another chemotherapy drug that is commonly used to treat LCH. It works by interfering with the growth of abnormal cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Cladribine</strong>: Cladribine is a chemotherapy drug that is sometimes used in more severe cases of LCH that do not respond to other treatments. It works by killing abnormal white blood cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Etoposide</strong>: Etoposide is a chemotherapy drug that is sometimes used in combination with other drugs to treat LCH. It works by interfering with the ability of abnormal cells to divide and grow.</span></li><li><span style=\"font-size:12pt;\"><strong>Cyclophosphamide</strong>: Cyclophosphamide is a chemotherapy drug that is sometimes used in combination with other drugs to treat LCH. It works by interfering with the growth and division of abnormal cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Steroids</strong>: Steroids are often used in conjunction with chemotherapy to help reduce inflammation and improve symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Immunotherapy</strong>: Immunotherapy is a newer treatment option that involves using drugs that stimulate the immune system to attack and kill the abnormal cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Surgery</strong>: In some cases, surgery may be needed to remove damaged or diseased tissue, particularly if it is causing significant problems or pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;A. Cyclophosphamide: Explanation</strong>: Cyclophosphamide is used in combination with other drugs to treat LCH by interfering with the growth and division of abnormal cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;B. Methotrexate: Explanation</strong>: Methotrexate is used to treat LCH by interfering with the growth of abnormal cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;C. Vinblastine: Explanation</strong>: Vinblastine is commonly used as the first-line treatment for LCH, particularly in children, by disrupting the growth of abnormal Langerhans cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;D. Vincristine: Explanation</strong>: Vincristine is not recommended for LCH. Other chemotherapy drugs like vinblastine are preferred for this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Langerhans Cell Histiocytosis (LCH) is treated with various chemotherapy drugs, but vincristine is not typically used for this condition. Vinblastine, methotrexate, cyclophosphamide, and other drugs are preferred for the management of LCH.</span></p>",
      "correct_choice_id": 27863,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13893,
      "choices": [
        {
          "id": 55533,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous steroids</span></p>"
        },
        {
          "id": 55534,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Intravenous antibiotics</span></p>"
        },
        {
          "id": 55535,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Bandage and padding of the eye</span></p>"
        },
        {
          "id": 55536,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Intravitreal antibiotics</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old male patient who had undergone an uneventful cataract surgery with intraocular lens implantation, presents with complaints of pain and visual disturbance in the operated eye, 36 hours post operatively. His eye is as shown below. What is the management of this condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-113.jpg\" alt=\"\" width=\"300\" height=\"167\"></span></p>",
      "unique_key": "Q9876767",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269456,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Intravitreal antibiotics</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows an inflamed eye with the presence hypopyon, which along with the history of a recent cataract surgery is suggestive of endophthalmitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Endophthalmitis is an inflammation of the inner structures of the eyeball associated with exudate pouring in the vitreous cavity, anterior chamber, and posterior chamber.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Modes of infection:</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\"><strong>Exogenous:&nbsp;</strong>following perforating injuries, perforation of infected corneal ulcers, or postoperative infections.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Endogenous or metastatic endophthalmitis:</strong> occurs rarely through the bloodstream from some infected focus.</span></li><li><span style=\"font-size:12.0pt;\">Secondary infections from surrounding structures: rare.</span></li></ol><ul><li><span style=\"font-size:12.0pt;\"><strong>Bacterial endophthalmitis:</strong> most frequent pathogens are gram-positive cocci, such as staphylococcus epidermidis and staphylococcus aureus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fungal endophthalmitis:</strong> comparatively rare, caused by aspergillus, fusarium, candida, etc.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cardinal features:</strong> Pain, lid swelling, and decreased vision. Inflammation of the eye, corneal edema, and hypopyon may also occur.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Intraocular fluid from anterior chamber or vitreous biopsy is sent for gram staining, KOH mount and culture.</span></li><li><span style=\"font-size:12.0pt;\">Intravitreal injection of antibiotics is the primary therapy. Patient needs to be monitored daily to assess for resolution of clinical symptoms and repeat intravitreal antibiotic injections may be given as required.</span></li><li><span style=\"font-size:12.0pt;\">Topical broadspectrum antibiotics, cycloplegics are also given simultaneously.</span></li><li><span style=\"font-size:12.0pt;\">Oral steroids may be given.</span></li><li><span style=\"font-size:12.0pt;\">Systemic antibiotics have no role in the management of endophthalmitis..</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/06/screenshot-2023-11-06-181028.png\" alt=\"\" width=\"1000\" height=\"619\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Intravenous steroids:</strong> Not the primary treatment for endophthalmitis. Steroids may be used to reduce inflammation but not as the main intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intravenous antibiotics:</strong> Systemic antibiotics have limited effectiveness due to poor penetration into the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bandage and padding of the eye:</strong> Provides no therapeutic benefit for endophthalmitis and delays appropriate treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intravitreal antibiotics are the primary treatment for endophthalmitis, a severe postoperative complication characterized by inflammation and hypopyon. Early and aggressive treatment is crucial to prevent vision loss.</span></p>",
      "correct_choice_id": 55536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10215,
      "choices": [
        {
          "id": 40826,
          "text": "<p><span style=\"font-size:12pt;\">Focal vitiligo</span></p>"
        },
        {
          "id": 40827,
          "text": "<p><span style=\"font-size:12pt;\">Segmental vitiligo</span></p>"
        },
        {
          "id": 40828,
          "text": "<p><span style=\"font-size:12pt;\">Piebaldism</span></p>"
        },
        {
          "id": 40829,
          "text": "<p><span style=\"font-size:12pt;\">Nevus depigmentosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most probable diagnosis for a young male presenting with Leucotrichia and lesions as depicted in the image is? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13553.jpg\" alt=\"\" width=\"200\" height=\"378\"></p>",
      "unique_key": "Q1650310",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269487,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Segmental vitiligo</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Localized, unilateral depigmented&nbsp;</strong>macules can be seen in the image. This characteristic and a history of <strong>leukotrichia</strong> point to the diagnosis of <strong>segmental vitiligo</strong> in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Vitiligo happens because the basal layer lacks melanocytes&nbsp;</strong>due to <strong>autoimmune destruction </strong>by<strong> auto antibodies.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The gradual loss of melanocytes causes a localized depigmentation to take place.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>It is categorized as:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Segmental vitiligo</strong>: This form of vitiligo is characterized by <strong>unilateral</strong> <strong>depigmented</strong> macules in a <strong>dermatomal or segmental</strong> pattern. The presence of <strong>Leucotrichia</strong> (<strong>white or colorless hair</strong>) within the lesion is a strong clinical indicator of segmental vitiligo. The image shows a pattern consistent with segmental vitiligo.</span></li><li><span style=\"font-size:12pt;\"><strong>Non-segmental vitiligo:</strong>&nbsp;which appears as <strong>bilateral macules</strong> distributed in an <strong>acrofacial</strong> pattern or scattered <strong>symmetrically</strong> over the entire <strong>body.</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Focal vitiligo</strong>: This is characterized by <strong>one or more macules</strong> or patches in one area <strong>without any recognizable pattern as shown in the image below</strong>.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/whatsapp-image-2023-12-01-at-163939-1.jpeg\" alt=\"\" width=\"700\" height=\"328\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Piebaldism</strong>: It is a rare <strong>autosomal dominant </strong>disorder that is present at <strong>birth.</strong> The hallmark of piebaldism is a <strong>white forelock as shown in the image below</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/25/picture10_Km1evDr.jpg\" alt=\"\" width=\"300\" height=\"391\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">The distribution of lesions is usually <strong>symmetrical</strong> and remains <strong>stable</strong> throughout <strong>life</strong>, which differs from the presentation in the image.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nevus depigmentosus</strong>: This is a <strong>congenital, stable</strong> <strong>hypopigmented</strong> patch that does <strong>not progress</strong> or change with time. Unlike vitiligo, it does <strong>not show</strong> <strong>Leucotrichia,</strong> and the lesion does <strong>not spread.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/25/picture11.jpg\" alt=\"\" width=\"400\" height=\"192\"></strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Segmental vitiligo&nbsp;</strong>presents with one or more macules in a <strong>dermatomal or segmental</strong> pattern, often accompanied by <strong>Leucotrichia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks Textbook of dermatology 9<sup>th</sup> Edition page no 88.34</strong></span></p>",
      "correct_choice_id": 40827,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10419,
      "choices": [
        {
          "id": 41642,
          "text": "<p><span style=\"font-size:12.0pt;\">There is hypertrophy of ductus arteriosus.</span></p>"
        },
        {
          "id": 41643,
          "text": "<p><span style=\"font-size:12.0pt;\">Coarctation distal to the origin of the left subclavian artery</span></p>"
        },
        {
          "id": 41644,
          "text": "<p><span style=\"font-size:12.0pt;\">Supply is from posterior to anterior thoracic artery.</span></p>"
        },
        {
          "id": 41645,
          "text": "<p><span style=\"font-size:12.0pt;\">Collaterals develop to supply upper limb.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with cold feet and a history of wearing socks even in the summers. On examination, lower limb pulses are diminished as compared to the radial pulse. Prominent radio femoral delay is present. What is the underlying condition? (INICET NOV 2022)</span></p>",
      "unique_key": "Q7346438",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269484,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Coarctation distal to the origin of the left subclavian artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of cold feet, wearing socks even in summer, diminished lower limb pulses compared to radial pulses, and prominent radiofemoral delay is characteristic of <strong>coarctation of the aorta</strong>. This congenital condition is characterized by a narrowing (coarctation) of the aorta, typically just distal to the origin of the left subclavian artery at the ductus arteriosus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Coarctation of the Aorta:&nbsp;</strong>This condition results in the obstruction of blood flow, leading to higher blood pressure in the upper limbs and lower blood pressure in the lower limbs. The radiofemoral delay is a classic sign.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Location of Coarctation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Postductal Coarctation (Adult Type):&nbsp;</strong>The constriction occurs distal to the ductus arteriosus. This type is more common and leads to the development of collateral circulation to bypass the obstruction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Predductal Coarctation (Infantile Type):&nbsp;</strong>The constriction occurs proximal to the ductus arteriosus, leading to different clinical features and often presenting in infancy.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Cold feet&nbsp;</strong>and preference for wearing socks may be due to poor perfusion in the lower extremities.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diminished lower limb pulses&nbsp;</strong>and <strong>radiofemoral delay</strong> are hallmark signs.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypertension&nbsp;</strong>in the upper extremities due to the coarctation.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hypertrophy of ductus arteriosus:&nbsp;</strong>This condition does not cause radiofemoral delay or the constellation of symptoms seen in coarctation of the aorta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Supply from posterior to anterior thoracic artery:&nbsp;</strong>This does not explain the clinical presentation, especially the radiofemoral delay.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Collaterals develop to supply upper limb:&nbsp;</strong>Collateral circulation is a compensatory mechanism that develops over time in coarctation of the aorta, primarily to supply blood to the lower extremities, not just the upper limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Coarctation of the aorta typically presents with cold feet, diminished lower limb pulses, and radiofemoral delay due to a narrowing of the aorta distal to the origin of the left subclavian artery.</span></p>",
      "correct_choice_id": 41643,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13926,
      "choices": [
        {
          "id": 55665,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 55666,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        },
        {
          "id": 55667,
          "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
        },
        {
          "id": 55668,
          "text": "<p><span style=\"font-size:12.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old male presented with symptoms of inability to flex the distal interphalangeal joint of the 4th and 5th digits. He was also not able to hold a piece of paper between his fingers. What is the likely site of injury?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-73_AZ2mWie.jpg\" alt=\"\" width=\"200\" height=\"434\"></span></p>",
      "unique_key": "Q7693527",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269464,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An ulnar nerve damage is suggested by the clinical scenario, which includes a positive card test and the inability to flex the distal interphalangeal joint of the 4th and 5th digits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely site of injury would thus be medial epicondyle: site C</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-74_ioAiv4S.jpg\" alt=\"\" width=\"500\" height=\"435\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Damage to the ulnar nerve at the medial epicondyle causes paralysis of the flexor carpi ulnaris (lack of ulnar deviation) and the medial half of the flexor digitorum profundus (loss of distal interphalangeal joint flexion). Hypothenar paralysis (which causes atrophy) and sensory loss are the results. Moreover, the extensor digitorum and flexor digitorum superficialis (provided by the radial nerve and median nerve, respectively) continue to function. The third and fourth digits are therefore not completely paralysed. The palmar interossei's fragility, which causes a loss of adduction, is what causes the positive card test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Head of the Humerus:&nbsp;</strong>Articulates with the shoulder joint. Injury here typically affects shoulder movement, not the distal functions like finger flexion or sensory issues associated with the ulnar nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intertubercular Groove:&nbsp;</strong>Houses the tendon of the biceps brachii. Mainly affects movements related to the biceps muscle, not ulnar nerve functions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lateral Epicondyle:&nbsp;</strong>Attachment site for forearm extensor muscles. Primarily involved in conditions like lateral epicondylitis, which causes localized pain rather than the broader sensory and motor deficits seen in ulnar nerve damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ulnar nerve branches and supply:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-75_X0ZDAMp.jpg\" alt=\"\" width=\"600\" height=\"842\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Superficial branch supplies palmaris brevis, skin on the palmar surface of medial 1½ fingers. The deep branch runs within the concavity of deep palmar arch and supplies all intrinsic muscles of the hand (except first 2 lumbricals and thenar muscles).</span></p>",
      "correct_choice_id": 55667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33870,
      "choices": [
        {
          "id": 135318,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></p>"
        },
        {
          "id": 135319,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></p>"
        },
        {
          "id": 135320,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethambutol</span></span></p>"
        },
        {
          "id": 135321,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyrazinamide</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti-tubercular drugs cause visual problems as an adverse effect?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Fmge Jan 2024)</span></span></p>",
      "unique_key": "Q8463608",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269489,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Ethambutol</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ethambutol is the anti-tubercular drug that can cause visual problems as an adverse effect. It is known for its potential to lead to optic neuritis, which can result in changes in visual acuity and color vision. Monitoring of vision is important during the use of ethambutol, and if visual disturbances occur, the drug may need to be discontinued to prevent further optic nerve damage.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Rifampicin:</strong> Rifampicin is not typically associated with visual problems as an adverse effect.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Isoniazid:</strong> Isoniazid is not known to cause visual problems. However, it is associated with hepatotoxicity and peripheral neuropathy as potential adverse effects.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Pyrazinamide:</strong> Pyrazinamide is not commonly associated with visual problems as an adverse effect.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ethambutol is the anti-tubercular drug known for its association with visual problems. It can cause optic neuritis and changes in color vision, which may be reversible upon discontinuation of the drug.</span></span></p>",
      "correct_choice_id": 135320,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47599,
      "choices": [
        {
          "id": 190007,
          "text": "<p><span style=\"font-size:12.0pt;\">Kartagener syndrome</span></p>"
        },
        {
          "id": 190008,
          "text": "<p><span style=\"font-size:12.0pt;\">Kallaman syndrome</span></p>"
        },
        {
          "id": 190009,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        },
        {
          "id": 190010,
          "text": "<p><span style=\"font-size:12.0pt;\">Samter syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An infertile patient came with a history of sinus inversus, sinusitis, and pulmonary infection. Which syndrome is likely to occur?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q9656423",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269463,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Kartagener syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener syndrome is a rare genetic disorder characterized by the <strong>triad of situs inversus (reversed positioning of the internal organs), chronic sinusitis, and bronchiectasis (irreversible dilation of the bronchi)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical features described in the question, including sinus inversus, sinusitis, and pulmonary infection (suggestive of bronchiectasis), are characteristic of Kartagener syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-172718.png\" alt=\"\" width=\"700\" height=\"297\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener syndrome is a subtype of primary ciliary dyskinesia (PCD), a genetic condition in which the cilia (hair-like structures responsible for movement) are dysfunctional or immotile. This leads to impaired mucociliary clearance, resulting in recurrent respiratory infections, sinusitis, and bronchiectasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Kallaman syndrome: </strong>This syndrome is characterized by hypogonadotropic hypogonadism (delayed or absent puberty) and anosmia (lack of sense of smell), but it is not associated with the clinical features mentioned in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cystic fibrosis:</strong> Although cystic fibrosis can lead to bronchiectasis, it is not typically associated with situs inversus or sinusitis as prominent features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Samter syndrome: </strong>This is a triad of asthma, nasal polyps, and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs). It does not involve situs inversus or the clinical presentation described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The triad of situs inversus, chronic sinusitis, and bronchiectasis is characteristic of Kartagener syndrome, which is a subtype of primary ciliary dyskinesia (PCD) resulting from dysfunctional cilia.</span></p>",
      "correct_choice_id": 190007,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57105,
      "choices": [
        {
          "id": 227809,
          "text": "<p><span style=\"font-size:12.0pt;\">Simple mastectomy</span></p>"
        },
        {
          "id": 227810,
          "text": "<p><span style=\"font-size:12.0pt;\">MRM (Modified Radical Mastectomy)</span></p>"
        },
        {
          "id": 227811,
          "text": "<p><span style=\"font-size:12.0pt;\">Radical mastectomy</span></p>"
        },
        {
          "id": 227812,
          "text": "<p><span style=\"font-size:12.0pt;\">Neoadjuvant chemotherapy followed by surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Image of a patient with large ulcerated breast cancer with liver metastasis. What is the management? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-115837.jpg\" alt=\"\" width=\"450\" height=\"408\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q8022234",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269479,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Simple mastectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient in the image has a large ulcerated breast tumor with confirmed liver metastasis, classifying the cancer as stage IV (T4, M1). In cases of stage IV breast cancer with distant metastasis, the primary goal of management shifts from curative to palliative care, focusing on improving quality of life and managing symptoms.</span></p><p><span style=\"font-size:12.0pt;\">For patients with large ulcerated tumors, palliative simple mastectomy may be considered to alleviate symptoms like pain, ulceration, discharge, or infection, which can significantly impact the patient’s quality of life. This procedure is not intended to cure but to provide local control of the tumor and improve comfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. MRM (Modified Radical Mastectomy):</strong> This is a more aggressive surgical approach that involves removal of the breast tissue along with axillary lymph nodes. It is typically reserved for curative intent in earlier stages of breast cancer without distant metastasis. It is not appropriate for palliation in stage IV disease with liver metastasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Radical mastectomy:</strong> This involves removal of the entire breast, underlying chest muscles, and axillary lymph nodes. This extensive procedure is rarely performed today and is not suitable for palliative care in metastatic disease due to its high morbidity without a survival benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neoadjuvant chemotherapy followed by surgery:</strong> Neoadjuvant chemotherapy is used in locally advanced breast cancer (LABC) to shrink tumors before surgery, but in the presence of distant metastasis (M1), systemic chemotherapy alone would be preferred for palliative purposes. Surgery would only follow if there was a significant symptomatic tumor burden requiring local control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with stage IV breast cancer with distant metastasis, such as liver metastasis, the primary focus is on palliation. Simple mastectomy may be performed to manage symptoms from a large ulcerated tumor, but more extensive surgeries or curative approaches are not indicated.</span></p>",
      "correct_choice_id": 227809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57568,
      "choices": [
        {
          "id": 229641,
          "text": "<p><span style=\"font-size:18px;\">4</span></p>"
        },
        {
          "id": 229642,
          "text": "<p><span style=\"font-size:18px;\">5</span></p>"
        },
        {
          "id": 229643,
          "text": "<p><span style=\"font-size:18px;\">4.5</span></p>"
        },
        {
          "id": 229644,
          "text": "<p><span style=\"font-size:18px;\">4,5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Calculate the median from the given set of observations: 2, 3, 4, 5, 6, 7, 4, 8. </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
      "unique_key": "Q3647583",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269488,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) 4.5</strong></span></p><p><br><span style=\"font-size:18px;\">The median is the middle value of a data set when arranged in ascending order. For an even number of observations, the median is found by taking the average of the two middle numbers. In this set, the values in ascending order are: 2, 3, 4, 4, 5, 6, 7, 8. Since there are 8 values (an even number), the two middle values are 4 and 5. The median is calculated by averaging these two values:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Median = (4+5)/2 = 4.5</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\">For an even number of observations, the median is the average of the two middle values when the data set is arranged in ascending order.</span></p>",
      "correct_choice_id": 229643,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44010,
      "choices": [
        {
          "id": 175699,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remove placenta and reposition the uterus</span></span></span></p>"
        },
        {
          "id": 175700,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Put uterus inside without removing the placenta</span></span></span></p>"
        },
        {
          "id": 175701,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shift to OT and insert the uterus back</span></span></span></p>"
        },
        {
          "id": 175702,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start Oxytocin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has just delivered a full-term baby and developed uterine inversion with the placenta still attached. What is the immediate next step?&nbsp;</span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q3668794",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269467,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Put uterus inside without removing the placenta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate management of uterine inversion involves repositioning the uterus before removing the placenta to prevent severe bleeding and shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Remove placenta and reposition the uterus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Removing the placenta before repositioning the uterus can lead to massive hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Shift to OT and insert the uterus back:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Immediate manual repositioning is crucial before shifting to an operating theatre.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Start Oxytocin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oxytocin is used after the uterus is repositioned to encourage contraction, not before.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of uterine inversion, the uterus should be repositioned with the placenta still attached to avoid significant bleeding, followed by medical management for uterine contraction.</span></span></span></p>",
      "correct_choice_id": 175700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24844,
      "choices": [
        {
          "id": 99337,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurofibroma</span></p>"
        },
        {
          "id": 99338,
          "text": "<p><span style=\"font-size:12.0pt;\">Leiomyoma</span></p>"
        },
        {
          "id": 99339,
          "text": "<p><span style=\"font-size:12.0pt;\">Schwannoma</span></p>"
        },
        {
          "id": 99340,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old male presented with hearing loss and tinnitus. A histology image is shown below. What can be the diagnosis for this patient?</span>(INICET MAY 2021)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/whatsapp-image-2023-07-04-at-1256120_page_17_page_19.jpg\" alt=\"\" width=\"300\" height=\"207\"></span></p>",
      "unique_key": "Q5141064",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269490,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ans. C) Schwannoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario and histology image showing Verocay bodies are suggestive of Schwannoma /Acoustic neuroma.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-102426.png\" alt=\"\" width=\"1000\" height=\"974\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Neurofibroma</strong> is&nbsp;a benign tumor that develops along nerve cells. Histology image shows wreath like multinucleated giant cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/whatsapp-image-2023-07-04-at-1256120_page_17_page_21.jpg\" alt=\"\" width=\"300\" height=\"243\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Leiomyoma</strong> on histology shows well-differentiated, regular, spindle-shaped smooth muscle cells with hyalinization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/whatsapp-image-2023-07-04-at-1256120_page_17_page_22.jpg\" alt=\"\" width=\"300\" height=\"259\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rhabdomyoma</strong> on microscopy shows enlarged myocytes with abundant glycogen. Post-processing, glycogen content gets reduced and look like thin strands.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/whatsapp-image-2023-07-04-at-1256120_page_17_page_23.jpg\" alt=\"\" width=\"300\" height=\"266\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Schwannoma is a benign tumor often associated with unilateral hearing loss and tinnitus, diagnosed via characteristic histological patterns and confirmed with MRI. It requires careful management, sometimes involving advanced surgical techniques such as Gamma Knife surgery.</span></p>",
      "correct_choice_id": 99339,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55502,
      "choices": [
        {
          "id": 221465,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pinguecula</span></span></span></p>"
        },
        {
          "id": 221466,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bitot&rsquo;s spots</span></span></span></p>"
        },
        {
          "id": 221467,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pterygium</span></span></span></p>"
        },
        {
          "id": 221468,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stocker&#39;s line</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin A deficiency is found to be associated with:</span></span></span></p>",
      "unique_key": "Q4705072",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269477,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Bitot&rsquo;s spots</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin A deficiency is a significant public health issue, especially in developing countries, and it is associated with various ocular manifestations collectively known as xerophthalmia. One of the most specific and classic signs of Vitamin A deficiency is the presence of <strong>Bitot&rsquo;s spots</strong>. These are foamy, whitish accumulations on the conjunctiva, typically located on the temporal side of the eye. They are caused by the buildup of keratin due to the lack of Vitamin A, which is essential for maintaining the health of the conjunctiva and cornea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pinguecula:</span></strong><span style=\"font-size:12.0pt\"> This is a common, benign, yellowish growth on the conjunctiva that is unrelated to Vitamin A deficiency. It is associated with aging and UV exposure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pterygium:</span></strong><span style=\"font-size:12.0pt\"> This is a growth of fleshy tissue that may extend onto the cornea. It is linked to UV exposure and chronic irritation but is not associated with Vitamin A deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Stocker&#39;s line:</span></strong><span style=\"font-size:12.0pt\"> This is an iron deposit line seen at the leading edge of a pterygium and is not related to Vitamin A deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO Classification of Xerophthalmia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-162907.png\" style=\"height:382px; width:1000px\" /></p>",
      "correct_choice_id": 221466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5918,
      "choices": [
        {
          "id": 23642,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.25 mg</span></span></span></p>"
        },
        {
          "id": 23643,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 mg</span></span></span></p>"
        },
        {
          "id": 23644,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20 mg</span></span></span></p>"
        },
        {
          "id": 23645,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">200 mg</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The maximum dose of PGF2 alpha in postpartum hemorrhage is?&nbsp;</span></span>(NEET PG 2019)</p>",
      "unique_key": "Q8729320",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269480,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 2 mg </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin F2 alpha (PGF2&alpha;), also known as carboprost, is used for the treatment of postpartum hemorrhage (PPH) due to uterine atony. The therapeutic regimen and maximum dosage are crucial for effective management and patient safety.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dose and Administration:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The approved dose for treating uterine atony with PGF2&alpha; is 0.25 mg administered intramuscularly (IM).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maximum Dose:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The maximum cumulative dose is 2 mg. This is achieved by administering a total of 8 doses of 0.25 mg each.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dosing Interval:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These doses can be repeated at intervals of 15 to 90 minutes, depending on the clinical response and the patient&#39;s condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraindications</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchial Asthma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> PGF2&alpha; can cause bronchoconstriction, which makes it contraindicated in patients with bronchial asthma.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suspected Amniotic Fluid Embolism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Due to its potential to cause pulmonary airway and vascular constriction, it is also contraindicated in cases of suspected amniotic fluid embolism.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 0.25 mg</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the single dose administered IM but not the cumulative maximum dose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 20 mg</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This dose is excessively high and not clinically recommended or safe.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 200 mg</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This dose is not applicable for human use and is far beyond the safe and recommended limits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The maximum dose of prostaglandin F2 alpha in the management of postpartum hemorrhage is 2 mg, administered in 0.25 mg increments intramuscularly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 480, DC Dutta&rsquo;s Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23643,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5601,
      "choices": [
        {
          "id": 22376,
          "text": "<p><span style=\"font-size:12.0pt;\">Study of fingerprints</span></p>"
        },
        {
          "id": 22377,
          "text": "<p><span style=\"font-size:12.0pt;\">Theory of exchange</span></p>"
        },
        {
          "id": 22378,
          "text": "<p><span style=\"font-size:12.0pt;\">Stature estimation</span></p>"
        },
        {
          "id": 22379,
          "text": "<p><span style=\"font-size:12.0pt;\">Forensic ballistics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is Edmond Locard known for?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q6111285",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Theory of exchange</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Edmond Locard discovered two principles:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Locard's Exchange Principle&nbsp;</strong>It states that whenever two bodies come in contact with each other, there is exchange of material between the two and so a criminal can be linked to crime</span></li><li><span style=\"font-size:12.0pt;\"><strong>Poroscopy:&nbsp;</strong>It is a method of identification through the comparison of the impressions of pores of sweat glands (present on palmar and plantar surfaces).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Study of fingerprints:&nbsp;</strong>Sir Francis Galton, developed the first classification system for fingerprints.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stature estimation:&nbsp;</strong>This field involves estimating an individual's height from skeletal remains.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Forensic ballistics:&nbsp;</strong>This deals with the examination of firearms, bullets, and bullet impacts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Edmond Locard is best known for Locard's Exchange Principle, which states that whenever two bodies come into contact, there is an exchange of materials, thereby linking criminals to crime scenes.</span></p>",
      "correct_choice_id": 22377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54812,
      "choices": [
        {
          "id": 218713,
          "text": "<p><span style=\"font-size:12.0pt;\">ERCP and Bile duct</span></p>"
        },
        {
          "id": 218714,
          "text": "<p><span style=\"font-size:12.0pt;\">ERCP and Pancreatic duct</span></p>"
        },
        {
          "id": 218715,
          "text": "<p><span style=\"font-size:12.0pt;\">Percutaneous transhepatic balloon catheter</span></p>"
        },
        {
          "id": 218716,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous catheter</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify what is depicted in the abdominal X-Ray?&nbsp;(FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-163215.png\" alt=\"\" width=\"300\" height=\"348\"></span></p>",
      "unique_key": "Q9193265",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269475,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) ERCP and Bile duct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The abdominal X-ray KUB image shows a stent, specifically a double J (DJ) stent, commonly used in surgeries. The appearance and orientation of the stent are key to identifying its location. In this case, the stent is positioned vertically, which indicates it is in the bile duct. The bile duct runs vertically in the body, and a biliary stent used in procedures like ERCP (Endoscopic Retrograde Cholangiopancreatography) would also be <strong>oriented vertically</strong>. Conversely, a stent in the pancreatic duct would be oriented horizontally due to the anatomical layout of the pancreatic duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ERCP and Pancreatic duct:</strong> A stent in the pancreatic duct would be <strong>oriented horizontally</strong>, not vertically, due to the horizontal course of the pancreatic duct. The given image shows a vertically oriented stent, which rules out this option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Percutaneous transhepatic balloon catheter:</strong> This type of catheter would have a different appearance and is not typically placed in a vertical orientation like the stent shown in the X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Subcutaneous catheter:</strong> This type of catheter is used for different purposes and would not appear as a vertical stent in the abdominal X-ray. It also wouldn't be located in the bile duct or pancreatic duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The vertical orientation of a stent on an abdominal X-ray is indicative of its placement in the bile duct, particularly in procedures involving ERCP.</span></p>",
      "correct_choice_id": 218713,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "FMGE",
        "ImageBased",
        "InstrumentsBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55488,
      "choices": [
        {
          "id": 221409,
          "text": "<p><span style=\"font-size:12.0pt;\">6 months</span></p>"
        },
        {
          "id": 221410,
          "text": "<p><span style=\"font-size:12.0pt;\">12 months</span></p>"
        },
        {
          "id": 221411,
          "text": "<p><span style=\"font-size:12.0pt;\">18 months</span></p>"
        },
        {
          "id": 221412,
          "text": "<p><span style=\"font-size:12.0pt;\">24 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Exclusive breastfeeding is recommended to be done till what age of the child? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q3023264",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269472,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) 6 months</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In India, exclusive breastfeeding is recommended until the baby is 6 months old, compared to 4 months in developed countries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Breastfeeding should continue until the child is 2 years old in India and 1 year in developed countries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Points to remember:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Breast milk provides about 65 kilocalories and 0.9 to 1.1 grams of protein per 100 ml.</span></li><li><span style=\"font-size:12.0pt;\">Rich in immunoglobulin A, crucial for the infant’s immune development, along with other immunoglobulins.</span></li><li><span style=\"font-size:12.0pt;\">Contains essential fatty acids like docosahexaenoic acid (DHA) and taurine, both important for brain development.</span></li><li><span style=\"font-size:12.0pt;\">Higher levels of lactose, iron, and water in breast milk compared to cow's milk, with better calcium to phosphorus ratio.</span></li><li><span style=\"font-size:12.0pt;\">Iron in breast milk has high absorption; though calcium is lower, its absorption is high.</span></li><li><span style=\"font-size:12.0pt;\">Casein to whey ratio is less than 1, beneficial for infants.</span></li><li><span style=\"font-size:12.0pt;\">Initiate breastfeeding as soon as possible after birth: within one hour after vaginal delivery and four hours after cesarean section, ideally at the delivery table.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Exclusive breastfeeding is recommended for the first 6 months of life to ensure the best possible health outcomes for the child.</span></p>",
      "correct_choice_id": 221409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54952,
      "choices": [
        {
          "id": 219269,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Edward syndrome</span></span></p>"
        },
        {
          "id": 219270,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner syndrome</span></span></p>"
        },
        {
          "id": 219271,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patau syndrome</span></span></p>"
        },
        {
          "id": 219272,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Down syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which trisomy is suggested by karyotyping results showing chromosomal defects? (FMGE JULY 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/27/5_62287365066771709315.jpg\" style=\"height:242px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1364128",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269471,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Edward syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The karyotyping result showing an extra chromosome at the level of chromosome 18 indicates Trisomy 18, which is characteristic of Edward syndrome. Edward syndrome is a genetic disorder caused by the presence of all or part of an extra 18th chromosome. This condition leads to severe developmental delays, congenital heart defects, and other abnormalities. The karyotype typically shows three copies of chromosome 18 instead of the usual two.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Turner syndrome:</span></strong><span style=\"font-size:12.0pt\"> Turner syndrome is not associated with trisomy. Instead, it is characterized by the presence of a single X chromosome (45,X) in females. It is a monosomy condition, not a trisomy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Patau syndrome:</span></strong><span style=\"font-size:12.0pt\"> Patau syndrome is associated with Trisomy 13, where there is an extra chromosome 13. The karyotype shows three copies of chromosome 13, not 18.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Down syndrome:</span></strong><span style=\"font-size:12.0pt\"> Down syndrome is caused by Trisomy 21, characterized by an extra chromosome 21. The karyotype shows three copies of chromosome 21, not 18.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Edward syndrome is caused by Trisomy 18, where the karyotype reveals an extra chromosome 18. This distinguishes it from other chromosomal disorders such as Down syndrome (Trisomy 21) and Patau syndrome (Trisomy 13)</span></span></span></p>",
      "correct_choice_id": 219269,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46449,
      "choices": [
        {
          "id": 185415,
          "text": "<p><span style=\"font-size:12.0pt;\">Category A</span></p>"
        },
        {
          "id": 185416,
          "text": "<p><span style=\"font-size:12.0pt;\">Category B</span></p>"
        },
        {
          "id": 185417,
          "text": "<p><span style=\"font-size:12.0pt;\">Category C</span></p>"
        },
        {
          "id": 185418,
          "text": "<p><span style=\"font-size:12.0pt;\">Category D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">As per WHO categorization of bioterrorism agents, Anthrax belongs to&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q6642596",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269462,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Category A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO categorizes bioterrorism agents into three main categories based on their potential impact on public health and their ease of dissemination.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Anthrax (Bacillus anthracis) is classified as a Category A agent, which includes the highest priority agents that pose the greatest risk to national security and public health.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Category A&nbsp;</strong>agents are easily disseminated or transmitted from person to person, cause high mortality rates, and have the potential for major public health impact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Category B:</strong> Includes agents that are moderately easy to disseminate and result in moderate morbidity rates and low mortality rates, require enhanced diagnostic capacity with enhanced surveillance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Category C:&nbsp;</strong>Includes NEW emerging pathogens that could be engineered for mass dissemination in the future because of their availability, ease of production and dissemination, and potential for high morbidity and mortality rates.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Category D:&nbsp;</strong>Not a recognized category by WHO for bioterrorism agents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-122625.jpg\" alt=\"\" width=\"1000\" height=\"658\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anthrax is the MC used bioterrorism agent</span></li><li><span style=\"font-size:12.0pt;\">Small pox is the most dangerous bioterrorism agent</span></li><li><span style=\"font-size:12.0pt;\">Botulism most lethal toxin wise bioterrorism agent</span></li></ul>",
      "correct_choice_id": 185415,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45842,
      "choices": [
        {
          "id": 182995,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate</span></p>"
        },
        {
          "id": 182996,
          "text": "<p><span style=\"font-size:12.0pt;\">Alanine</span></p>"
        },
        {
          "id": 182997,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
        },
        {
          "id": 182998,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ammonia is transported from the brain to the liver in the form of which of the following amino acids?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q8539672",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Glutamine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ammonia is transported from the brain to the liver primarily in the form of glutamine.</span></p><p><span style=\"font-size:12.0pt;\">This is because glutamine can safely carry ammonia through the bloodstream to the liver, where the urea cycle converts it into urea for excretion.</span></p><p><span style=\"font-size:12.0pt;\">The liver's urea cycle is the primary site for detoxifying ammonia, a neurotoxic byproduct of amino acid metabolism.</span></p><p><span style=\"font-size:12.0pt;\">Glutamine plays a crucial role in this process by acting as a carrier molecule that neutralizes ammonia, thus preventing its accumulation and potential toxicity in the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glutamate:</strong> While glutamate is involved in ammonia metabolism, it is not the primary transporter of ammonia from the brain to the liver. Instead, glutamate is often converted to glutamine for this purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Alanine:</strong> Alanine transports ammonia primarily from <strong>muscle tissues</strong> to the liver. It is part of the glucose-alanine cycle, which helps in the conversion of pyruvate to glucose in the liver.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glycine:</strong> Glycine does not play a significant role in ammonia transport from the brain to the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glutamine is the primary amino acid responsible for transporting ammonia from the brain to the liver.</span></p>",
      "correct_choice_id": 182998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33869,
      "choices": [
        {
          "id": 135314,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 135315,
          "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 135316,
          "text": "<p><span style=\"font-size:12.0pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 135317,
          "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is the preferred drug for treatment of post-menopausal breast cancer?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q6623130",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269454,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D. Anastrozole</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Aromatase inhibitors like anastrozole and letrozole are&nbsp; considered the preferred drugs for the treatment of hormone receptor-positive breast cancer in post-menopausal women whereas tamoxifen is considered drug of choice in pre-menopausal women. Anastrozole is an aromatase inhibitor whereas tamoxifen works as a selective estrogen receptor modulator (SERM), both are effective in blocking the effects of estrogen on breast cancer cells. Methotrexate may be used in breast cancer treatment, however it is not a first line drug. On the other hand, raloxifene is a SERM used for treatment of osteoporosis</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Methotrexate:</strong> Methotrexate is a chemotherapy drug used in the treatment of various cancers, including some types of breast cancer. However, it is not typically the first-line choice for post-menopausal breast cancer.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Raloxifene:</strong> Raloxifene is a selective estrogen receptor modulator (SERM) primarily used for osteoporosis and the prevention of breast cancer, rather than its treatment.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Tamoxifen:</strong> Tamoxifen is a widely used medication for the treatment of hormone receptor-positive breast cancer in both pre-menopausal and post-menopausal women. It is often the preferred choice for breast cancer in pre-menopausal female.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Anastrozole is an aromatase inhibitor and is drug of choice for treatment of breast cancer (which is estrogen receptor positive) in post-menopausal females.</span></p>",
      "correct_choice_id": 135317,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11309,
      "choices": [
        {
          "id": 45202,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CXR PA view</span></span></p>"
        },
        {
          "id": 45203,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trans-esophageal echocardiography</span></span></p>"
        },
        {
          "id": 45204,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI</span></span></p>"
        },
        {
          "id": 45205,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Troponin assay</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male presented with substernal chest discomfort. On examination, he was hypotensive, drowsy, and had unequal pulses. Which of the following investigations would be the best in this situation to ascertain the diagnosis?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>",
      "unique_key": "Q5528001",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269457,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Trans-esophageal echocardiography</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presentation of acute chest pain, hypotension, drowsiness, and unequal pulses strongly suggests aortic dissection. <strong>Aortic dissection</strong> is a life-threatening condition that requires immediate diagnosis and management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trans-esophageal echocardiography (TEE) is highly sensitive and specific for diagnosing aortic dissection. It can be performed at the bedside, making it ideal for unstable patients. TEE provides detailed images of the aorta and can quickly confirm the presence of an intimal flap, a characteristic finding in aortic dissection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">If the patient&nbsp;has been stable, then preferred investigation of choice is CT angiography.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. CXR PA view:</span></strong><span style=\"font-size:12.0pt\"> A chest X-ray (CXR) might show a widened mediastinum, which can be a clue to aortic dissection, but it is not definitive. It lacks the sensitivity and specificity needed for a rapid and accurate diagnosis in an emergency setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. MRI:</span></strong><span style=\"font-size:12.0pt\"> While MRI can provide excellent detail, it is not suitable for acutely unstable patients due to the time required for the scan and the need to transport the patient to the MRI suite. It is not practical in an emergency setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Troponin assay:</span></strong><span style=\"font-size:12.0pt\"> Troponin assays are used to diagnose myocardial infarction, not aortic dissection. Although troponins can be elevated in some cases of aortic dissection, they do not provide definitive diagnostic information about the dissection itself.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the setting of suspected aortic dissection, especially in an unstable patient, trans-esophageal echocardiography (TEE) is the best diagnostic tool due to its high sensitivity and ability to be performed at the bedside, providing rapid and accurate confirmation of the diagnosis.</span></span></p>",
      "correct_choice_id": 45203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5203,
      "choices": [
        {
          "id": 20785,
          "text": "<p><span style=\"font-size:12.0pt;\">Life history has 4 stages</span></p>"
        },
        {
          "id": 20786,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Larvae have 3 pairs of legs</span></p>"
        },
        {
          "id": 20787,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿The entire life cycle takes about 15 days</span></p>"
        },
        {
          "id": 20788,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Male parasite burrows into the epidermis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female developed pruritic papules with excoriated plaques in the interdigital web spaces. Later the lesion spread to the groin and under-surface of the breasts. The lady gives a history of intense pruritus which is more severe at night. Given below is the organism responsible for this condition. Identify the wrong statement about the same? (NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_FRISI12.jpg\" alt=\"\" width=\"400\" height=\"237\"></span></p>",
      "unique_key": "Q9812563",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269458,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Male parasite burrows into the epidermis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This statement is incorrect because it is the female mite, not the male, that burrows into the skin. The male mites mainly stay on the surface of the skin and do not create burrows like the females do.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical background is probably suggestive Scabies. The given image depicts Itch mite also called <strong>Sarcoptes scabiei</strong>. The female parasite burrows into the <strong>stratum corneum</strong> layer of the epidermis and <strong>lays eggs in the burrow</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A single female may lay about 30 eggs at a rate of 2 to 3 per day, and ultimately dies at the end of the burrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The life cycle has 4 stages<strong>: Egg, Larva, Nymph, and Adult</strong>. The adult mites live for 1 to 2 months.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Itching is a hypersensitivity reaction to the eggs and dead parasite in the epidermis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Permethrin cream - 5% is the treatment of choice.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Life history has 4 stages:</strong> The lifecycle of Sarcoptes scabiei consists of the egg, larva, nymph, and adult stages, correctly described in the statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Larvae have 3 pairs of legs:</strong> The larvae of the scabies mite indeed have three pairs of legs, distinguishing them from the adult mites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The entire life cycle takes about 15 days:</strong> The lifecycle from egg to mature mite, under ideal conditions, typically spans around 15 days, making this statement accurate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The female Sarcoptes scabiei mite is responsible for burrowing into the skin and laying eggs, which leads to the intense itching and characteristic rash seen in scabies. Recognizing the specific behavior of the female mite in the transmission and lifecycle of scabies is crucial for effective diagnosis and management of the condition.</span></p>",
      "correct_choice_id": 20788,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11114,
      "choices": [
        {
          "id": 44422,
          "text": "<p><span style=\"font-size:18px;\">It is exclusively given in the deltoid</span></p>"
        },
        {
          "id": 44423,
          "text": "<p><span style=\"font-size:18px;\">The dose is 20 IU/kg</span></p>"
        },
        {
          "id": 44424,
          "text": "<p><span style=\"font-size:18px;\">Not given after 7 days of the 1st dose of the vaccine</span></p>"
        },
        {
          "id": 44425,
          "text": "<p><span style=\"font-size:18px;\">If human RIG is unavailable, equine is preferred</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A physician is preparing to administer post-exposure prophylaxis for a patient who has been bitten by a potentially rabid animal. Which of the following statements about the administration of rabies immunoglobulin (RIG) is INCORRECT? </strong><i><strong>[INICET MAY 2022]</strong></i></span></p>",
      "unique_key": "Q5207248",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269473,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) It is exclusively given in the deltoid</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Dose of Human Rabies Immunoglobulin (HRIg): 20 IU/kg body weight</span></li><li><span style=\"font-size:18px;\">Dose of Equine Rabies Immunoglobulin (ERIg): 40 IU/kg body weight</span></li><li><span style=\"font-size:18px;\">RIg must be given as soon as possible</span></li><li><span style=\"font-size:18px;\">RIg is NOT recommended beyond the 7th day of starting first dose of vaccine</span></li><li><span style=\"font-size:18px;\">RIg must never be given Intravenously</span></li><li><span style=\"font-size:18px;\">Entire dose of RIg (or as much as possible) must be infiltrated around the wound(s) site(s).</span></li><li><span style=\"font-size:18px;\">Remaining dose, if any, must be given Intramuscularly in deltoid</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Rabies immunoglobulin (RIG) should be infiltrated around the wound site and any remaining dose given intramuscularly, preferably in the deltoid, but it is not exclusively given in the deltoid.</span></li></ul>",
      "correct_choice_id": 44422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55505,
      "choices": [
        {
          "id": 221477,
          "text": "<p><span style=\"font-size:12.0pt;\">McNaughton rule</span></p>"
        },
        {
          "id": 221478,
          "text": "<p><span style=\"font-size:12.0pt;\">Durham's rule</span></p>"
        },
        {
          "id": 221479,
          "text": "<p><span style=\"font-size:12.0pt;\">Currens rule</span></p>"
        },
        {
          "id": 221480,
          "text": "<p><span style=\"font-size:12.0pt;\">Irresistible impulse test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person who at the time of commission of the offense was of unsound mind, is exempt if he didn't know the nature of the act or its consequences. This rule is known as: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q4317951",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269455,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) McNaughton rule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>McNaughton rule</strong>, also known as the <strong>legal test or right-wrong test</strong>, is the standard used in India to determine criminal responsibility for individuals with mental illness. According to this rule, a person is exempt from criminal responsibility if, at the time of the commission of the offense, they were suffering from a mental disorder that rendered them incapable of understanding the nature of their act or knowing that it was wrong. This rule emphasizes the individual's ability to understand the act, rather than their ability to control their behavior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The rule is codified in Indian law under Section 84 Indian Penal Code (IPC) <strong>(Now, 22 BNS)</strong> and has been the primary standard for assessing the criminal liability of mentally ill offenders in India. If a <strong>person can understand that their actions are wrong, they are held responsible; otherwise, they are not.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Various rules related to the criminal responsibility of mentally ill individuals:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>McNaughten Rule</strong>: This is a legal test that focuses on whether the person knew right from wrong at the time of the offense. This is also referenced in Section 84 of the Indian Penal Code (IPC).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Irresistible Impulse Test</strong>: Indicates that a person is not responsible if they acted on an uncontrollable impulse despite knowing the act was wrong.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Durham Rule</strong>: A person is not criminally responsible if the unlawful act was the product of a mental disease or defect.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Currens Rule</strong>: States that a person is not responsible if they lacked the capacity to conform to the requirements of the law.</span></li><li><span style=\"font-size:12.0pt;\"><strong>American Law of Institute Test</strong>: A person is not responsible if they lacked:</span><ul><li><span style=\"font-size:12.0pt;\">Adequate capacity to appreciate the criminality of their conduct due to a mental disease or defect (cognitive insanity).</span></li><li><span style=\"font-size:12.0pt;\">Adequate capacity to conform their conduct to the requirements of law (volitional insanity).</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Doctrine of Partial Responsibility</strong>: This implies that while a person may be responsible, their mental illness is considered as a mitigating factor, potentially leading to reduced culpability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Durham's rule:</strong> This rule states that an individual is not criminally responsible if their unlawful act was the product of mental disease or defect. It focuses on the presence of a mental disease or defect as the cause of the unlawful act, rather than the individual's understanding of the nature of the act.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Currens rule:</strong> This rule states that an individual is not criminally responsible if they lacked the capacity to conform their conduct to the requirements of the law due to mental illness. It emphasizes the individual's ability to conform their behavior to legal standards.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Irresistible impulse test:</strong> This test states that an individual is not criminally responsible if, due to mental illness, they were unable to control their actions or resist the impulse to commit the act, even if they understood the nature of the act and that it was wrong.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In India, the McNaughton rule is used to determine criminal responsibility for individuals with mental illness. According to this rule, a person is exempt from criminal responsibility if they were unable to understand the nature of their act or know that it was wrong due to their mental condition.</span></p>",
      "correct_choice_id": 221477,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10335,
      "choices": [
        {
          "id": 41306,
          "text": "<p><span style=\"font-size:12.0pt;\">33 ml/min/1.73 m2 BSA</span></p>"
        },
        {
          "id": 41307,
          "text": "<p><span style=\"font-size:12.0pt;\">40 ml/min/1.73 m2 BSA</span></p>"
        },
        {
          "id": 41308,
          "text": "<p><span style=\"font-size:12.0pt;\">55 ml/min/1.73 m2 BSA</span></p>"
        },
        {
          "id": 41309,
          "text": "<p><span style=\"font-size:12.0pt;\">80 ml/min/1.73 m2 BSA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old male child with a body weight of 15kg and height of 100cm is admitted with renal failure. His blood urea was 100 mg/dL and serum creatinine was 1 mg/dL. What is the closest calculated eGFR in the patient? (INICET MAY 2022)</span></p>",
      "unique_key": "Q2150515",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269459,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 40 ml/min/1.73 m2 BSA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step-by-Step Calculation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 1: Identify the appropriate k value</strong></span></p><p><span style=\"font-size:12.0pt;\">For a 4-year-old child: k = 0.413</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 2: Apply the formula</strong></span></p><p><span style=\"font-size:12.0pt;\">eGFR = k × Height / Serum Creatinine</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 3: Substitute values</strong></span></p><p><span style=\"font-size:12.0pt;\">eGFR = 0.413 × 100 / 1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 4: Calculate</strong></span></p><p><span style=\"font-size:12.0pt;\">eGFR = 41.3 / 1 = 41.3 ml/min/1.73 m²</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 5: Round to nearest option</strong></span></p><p><span style=\"font-size:12.0pt;\">41.3 ≈ 40 ml/min/1.73 m² BSA</span><br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The estimated Glomerular Filtration Rate (eGFR) in pediatric patients can be calculated using the Schwartz formula, which is widely used in clinical practice. The formula takes into account the patient's height and serum creatinine levels, along with a constant value that is adjusted for age and sex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The modified Schwartz formula is most commonly used for this purpose. It is given as:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-095909.png\" alt=\"\" width=\"400\" height=\"81\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For children aged 1 to 16 years, the constant k is typically 0.413</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the child's height of 100 cm and serum creatinine of 1 mg/dL:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-095949.png\" alt=\"\" width=\"500\" height=\"48\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The closest value provided in the options is 40 ml/min/1.73 m² BSA, which is therefore the correct answer</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand and apply the Schwartz formula for estimating eGFR in pediatric patients based on height and serum creatinine levels.</span></p>",
      "correct_choice_id": 41307,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5748,
      "choices": [
        {
          "id": 22964,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obesity</span></span></span></span></p>"
        },
        {
          "id": 22965,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyhydramnios</span></span></span></span></p>"
        },
        {
          "id": 22966,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia</span></span></span></span></p>"
        },
        {
          "id": 22967,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous manual removal of placenta</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not considered as a factor for a high-risk pregnancy?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q8757468",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269465,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Previous manual removal of placenta</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous manual removal of the placenta does not automatically categorize a subsequent pregnancy as high-risk. High-risk pregnancies are characterized by various factors that may complicate the pregnancy or pose risks to the mother and fetus. These factors include existing health conditions, certain lifestyle factors, age-related risks, and specific pregnancy conditions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-risk pregnancy factors according to the NIH include:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Existing health conditions:</span></span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetes</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autoimmune diseases</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS (Polycystic Ovary Syndrome)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid disorders</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obesity</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine fibroids</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age:</span></span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adolescence</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First-time pregnancy at age &gt;35 years</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle factors:</span></span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcohol consumption</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Smoking</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug use</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnancy conditions:</span></span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple pregnancy</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational diabetes mellitus (GDM)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre-eclampsia</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous preterm birth</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital or chromosomal anomalies</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyhydramnios or oligohydramnios</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rh iso-immunization</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antepartum hemorrhage</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal growth restriction</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Obesity</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Obesity is a significant factor for a high-risk pregnancy as it is associated with various complications such as gestational diabetes, pre-eclampsia, and increased risk of cesarean delivery.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Polyhydramnios</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Polyhydramnios, which is an excessive amount of amniotic fluid, can lead to complications such as preterm labor and fetal malformations, making it a high-risk condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Anemia</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Anemia during pregnancy can affect the health of both the mother and the fetus, leading to conditions such as preterm birth and low birth weight, thus categorizing it as high-risk.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous manual removal of the placenta is not considered a factor for categorizing a subsequent pregnancy as high-risk.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: https://www.nichd.nih.gov/health/topics/high-risk</span></span></strong></span></span></p>",
      "correct_choice_id": 22967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55489,
      "choices": [
        {
          "id": 221413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">25%</span></span></span></p>"
        },
        {
          "id": 221414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">50%</span></span></span></p>"
        },
        {
          "id": 221415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">90%</span></span></span></p>"
        },
        {
          "id": 221416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">100%</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Case fatality rate of the disease rabies is: (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q6963050",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269460,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) 100%.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rabies is one of the deadliest infectious diseases, with a case fatality rate approaching 100%. This means that once clinical symptoms of rabies appear, the disease is almost always fatal, making it the highest fatality rate for any known disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The case fatality rate is calculated by dividing the number of deaths due to a disease by the number of diagnosed cases of that disease and then multiplying by 100 to express it as a percentage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The reason rabies has such a high case fatality rate is due to the virus&#39;s effects on the central nervous system, leading to acute encephalitis (inflammation of the brain). Once symptoms develop, there is no effective treatment, and death usually occurs within days.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Case fatality rate (CFR) is used to measure the virulence of organism or killing power of a disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CFR for COVID-19 and Chickenpox is about 1%.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Measles has a CFR of 3%.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rabies has the highest CFR at nearly 100%, with no cure available once symptoms appear.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 221416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11240,
      "choices": [
        {
          "id": 44926,
          "text": "<p><span style=\"font-size:12.0pt;\">IV verapamil</span></p>"
        },
        {
          "id": 44927,
          "text": "<p><span style=\"font-size:12.0pt;\">IV adenosine</span></p>"
        },
        {
          "id": 44928,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid massage</span></p>"
        },
        {
          "id": 44929,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchronized cardioversion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old female patient is brought to the ER in a state of unconsciousness. Her BP is 70/50 mm of Hg and her ECG is shown below. What is the next best step in the management of her condition?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/screenshot-2024-10-01-144116.png\" alt=\"\" width=\"400\" height=\"203\"></p>",
      "unique_key": "Q6475864",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269452,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Synchronized cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Any <strong>hemodynamically unstable rhythm, requires synchronized cardioversion</strong> (Shock delivered in sync with R wave <strong>to prevent R-on-T phenomenon</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;</strong>AV Nodal blockers are used if <i>hemodynamically stable.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;</strong>Maximum of 30mg of adenosine can be tried if patient is <i>Hemodynamically Stable.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>Carotid massage is not recommended for hemodynamically unstable patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-110009.jpg\" alt=\"\" width=\"1000\" height=\"353\"></strong></span></p>",
      "correct_choice_id": 44929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13619,
      "choices": [
        {
          "id": 54437,
          "text": "<p><span style=\"font-size:12pt;\">Phimosis</span></p>"
        },
        {
          "id": 54438,
          "text": "<p><span style=\"font-size:12pt;\">Urethral Stricture</span></p>"
        },
        {
          "id": 54439,
          "text": "<p><span style=\"font-size:12pt;\">Posterior urethral valve</span></p>"
        },
        {
          "id": 54440,
          "text": "<p><span style=\"font-size:12pt;\">Retrocaval ureter</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition that does not lead to bilateral hydronephrosis?&nbsp;</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q9908554",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269474,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Retrocaval ureter</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Retrocaval ureter is a rare congenital anomaly where the right ureter passes behind the inferior vena cava (IVC) and gets compressed, leading to right-sided hydronephrosis. This condition does not cause bilateral hydronephrosis because it only affects the right ureter.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Retrocaval ureter, also known as circumcaval ureter, is a condition where the right ureter passes behind the IVC, causing compression and right-sided hydronephrosis, but it does not affect the left ureter, thus not leading to bilateral hydronephrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Phimosis: </strong>Phimosis, a condition where the foreskin cannot be fully retracted over the glans penis, can lead to urinary retention and subsequent bilateral hydronephrosis if severe and left untreated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Urethral Stricture: </strong>A urethral stricture is a narrowing of the urethra which can obstruct urine flow and cause bilateral hydronephrosis if the obstruction is significant and near the bladder neck or urethra.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Posterior urethral valve: </strong>Posterior urethral valves are congenital obstructive membranes in the posterior male urethra. They cause significant obstruction, leading to bilateral hydronephrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Retrocaval ureter is a condition that affects only the right ureter, leading to right-sided hydronephrosis and does not cause bilateral hydronephrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/01/untitled-545.jpg\" alt=\"\" width=\"400\" height=\"310\"></span></p>",
      "correct_choice_id": 54440,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13015,
      "choices": [
        {
          "id": 52022,
          "text": "<p><span style=\"font-size:12.0pt;\">Shearing force</span></p>"
        },
        {
          "id": 52023,
          "text": "<p><span style=\"font-size:12.0pt;\">Impact of a semi sharp-edged object</span></p>"
        },
        {
          "id": 52024,
          "text": "<p><span style=\"font-size:12.0pt;\">Overstretching of skin and subcutaneous tissue</span></p>"
        },
        {
          "id": 52025,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Tissue crushed between weapon and underlying bone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old alcoholic comes to the casualty after being hurt in a fight with a stranger. A lacerated wound is seen over his skull. Which of the following is the correct mechanism of this lacerated wound? (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-31.jpg\" alt=\"\" width=\"300\" height=\"222\"></span></p>",
      "unique_key": "Q8752823",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269468,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D. Tissue crushed between weapon and underlying bone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The laceration shown above is an&nbsp;<strong>incised looking lacerated wound.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Shearing force:&nbsp;</strong>Shearing force typically causes a different type of laceration, not the incised-like laceration seen in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Impact of a semi sharp-edged object:&nbsp;</strong>This might cause a different wound pattern, more akin to a cut or a clean incision rather than a laceration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Overstretching of skin and subcutaneous tissue:&nbsp;</strong>This causes stretch lacerations, which do not match the appearance of the wound shown.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational objective</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Classification of a Laceration:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Split laceration (incised-like laceration</strong>): When the skin is crushed between two hard objects.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Incised-looking lacerated wound&nbsp;</strong>It is seen where the skin overlies an area of the bone where there is scanty underlying subcutaneous tissue such as the scalp, forehead, shin.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Avulsed laceration:&nbsp;</strong>A lesion where the skin separates or peels off by tearing from the underlying tissues.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Tears:&nbsp;</strong>Tearing of skin and subcutaneous tissue from localized impact</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Stretch laceration:&nbsp;</strong>It occurs due to the over-stretching of the skin, beyond its elasticity.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Cut laceration:&nbsp;</strong>Injury by a heavy sharp-edged instrument like axe.</span></p></li></ul>",
      "correct_choice_id": 52025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55764,
      "choices": [
        {
          "id": 222489,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methylphenidate: alpha agonist</span></span></span></p>"
        },
        {
          "id": 222490,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dexmethylphenidate or Dextroamphetamine</span></span></span></p>"
        },
        {
          "id": 222491,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atomoxetine: antidepressant</span></span></span></p>"
        },
        {
          "id": 222492,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serotonin and norepinephrine reuptake inhibitors</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following drugs is NOT used as a first line therapy for ADHD? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q6322024",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269486,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Serotonin and norepinephrine reuptake inhibitors</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Attention Deficit Hyperactivity Disorder (ADHD) is commonly treated with stimulant medications, which are the first line of treatment. The main drugs of choice include methylphenidate, dexmethylphenidate, and dextroamphetamine. These medications work by increasing dopamine and norepinephrine levels in the brain, improving concentration and reducing impulsivity and hyperactivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atomoxetine, although not a stimulant, is also used as a treatment option for ADHD. It works as a selective norepinephrine reuptake inhibitor and is considered a non-stimulant alternative, especially useful in patients who may not respond well to stimulants or who have contraindications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Serotonin and norepinephrine reuptake inhibitors (SNRIs)</span></strong><span style=\"font-size:12.0pt\">, such as venlafaxine and duloxetine, are primarily used as antidepressants and are not typically used as first-line or preferred treatments for ADHD. These medications target different neurotransmitter systems and do not specifically address the core symptoms of ADHD as effectively as stimulants or atomoxetine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Methylphenidate: alpha agonist:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect because methylphenidate is a stimulant and a common first-line treatment for ADHD, although it is not an alpha agonist. It increases dopamine and norepinephrine activity in the brain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dexmethylphenidate or Dextroamphetamine:</span></strong><span style=\"font-size:12.0pt\"> Dexmethylphenidate is a derivative of methylphenidate and is also a drug of choice for ADHD, working similarly to increase dopamine and norepinephrine levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dextroamphetamine is a stimulant that is often used in the management of ADHD due to its efficacy in increasing dopamine and norepinephrine release, which helps in reducing ADHD symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Atomoxetine: antidepressant:</span></strong><span style=\"font-size:12.0pt\"> Although it is referred to as an antidepressant, atomoxetine is actually a non-stimulant specifically approved for the treatment of ADHD, making it a valid option for this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serotonin and norepinephrine reuptake inhibitors (SNRIs) are not the drugs of choice for ADHD, whereas stimulants like methylphenidate and dextroamphetamine, and non-stimulants like atomoxetine, are preferred treatments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Remember - </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drugs used:</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methylphenidate: alpha agonist</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dx methylphenidate</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dextro amphetamine</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atomoxetine: antidepressant</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tricyclic antidepressants like</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Imipramine</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clonidine, guanfacine</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 222492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14138,
      "choices": [
        {
          "id": 56513,
          "text": "<p><span style=\"font-size:12.0pt;\">Jaundice</span></p>"
        },
        {
          "id": 56514,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotension</span></p>"
        },
        {
          "id": 56515,
          "text": "<p><span style=\"font-size:12.0pt;\">Altered sensorium</span></p>"
        },
        {
          "id": 56516,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematemesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a suspected case of cholangitis in a 47-year-old woman, what other component besides abdominal pain does not comprise Reynold's pentad? (INICET NOV 2021)</span></p>",
      "unique_key": "Q9132764",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269476,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hematemesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hematemesis (vomiting of blood) is not a component of Reynold's pentad. Reynold's pentad includes: jaundice, fever, abdominal pain, altered sensorium, and hypotension. Hematemesis can be a symptom of various other gastrointestinal issues but is not typically associated with cholangitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Cholangitis is an infection of the common bile duct caused by obstruction and increased pressure due to CBD stones.</span></li><li><span style=\"font-size:12.0pt;\">The classical triad of cholangitis (Charcot) is fever, right upper quadrant pain, and jaundice.</span></li><li><span style=\"font-size:12.0pt;\">If left untreated, cholangitis can progress to Reynold's pentad with hypotension and altered mental status due to sepsis.</span></li><li><span style=\"font-size:12.0pt;\">Abdominal ultrasound is used to diagnose biliary stones and bile duct dilatations in cholangitis.</span></li><li><span style=\"font-size:12.0pt;\">Treatment for cholangitis includes broad-spectrum antibiotics, rehydration, and biliary drainage using endoscopic retrograde cholangiopancreatography (ERCP).</span></li><li><span style=\"font-size:12.0pt;\">Biliary stones are the primary cause of cholangitis and can be removed by endoscopic sphincterotomy during ERCP.</span></li></ol>",
      "correct_choice_id": 56516,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50115,
      "choices": [
        {
          "id": 200019,
          "text": "<p><span style=\"font-size:12.0pt;\">Broca's aphasia</span></p>"
        },
        {
          "id": 200020,
          "text": "<p><span style=\"font-size:12.0pt;\">Wernicke's aphasia</span></p>"
        },
        {
          "id": 200021,
          "text": "<p><span style=\"font-size:12.0pt;\">Conduction aphasia</span></p>"
        },
        {
          "id": 200022,
          "text": "<p><span style=\"font-size:12.0pt;\">Global aphasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old patient is brought to the ER following a suspected stroke. The patient is unable to speak fluently, though he understands the given instructions. Which category of aphasia is most likely present in the patient? (FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q7931189",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269478,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Broca's aphasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient in the question exhibits symptoms consistent with Broca's aphasia, also known as motor aphasia. In Broca's aphasia, the patient has difficulty with speech production and articulation but maintains relatively intact language comprehension. This is evident from the fact that the patient understands the given instructions but is unable to speak fluently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Broca's area, located in the frontal lobe (Brodmann areas 44 and 45), is responsible for speech production and articulation. Damage to this area, often caused by a stroke, results in Broca's aphasia. Patients with Broca's aphasia struggle with fluent speech but can typically understand language, as the Wernicke's area remains unaffected.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/22/1_hJkyQEo.jpg\" alt=\"\" width=\"700\" height=\"538\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Wernicke's aphasia</strong> : This is a form of sensory aphasia where patients have difficulty understanding language but can produce fluent, albeit meaningless, speech. Wernicke’s area is located at the Posterior part of area no 22. This is associated with hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Conduction aphasia</strong> : In this type of aphasia, the patient can understand and produce language, but there is a disconnect between the Wernicke's area and the Broca's area (Brodmann areas 39 and 40). This results in difficulty repeating words or phrases, which is not mentioned in the patient's case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Global aphasia</strong> : This is a severe form of aphasia involving both Broca's and Wernicke's areas, leading to impairments in both language production and comprehension. The patient in the question does not exhibit signs of impaired comprehension, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Broca's aphasia, or motor aphasia, is characterized by difficulty in speech production and articulation while language comprehension remains relatively intact. It is caused by damage to Broca's area (Brodmann areas 44 and 45) in the frontal lobe, often due to a stroke.</span></p>",
      "correct_choice_id": 200019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55395,
      "choices": [
        {
          "id": 221041,
          "text": "<p><span style=\"font-size:12.0pt;\">Thymidylate synthetase</span></p>"
        },
        {
          "id": 221042,
          "text": "<p><span style=\"font-size:12.0pt;\">DNA polymerase</span></p>"
        },
        {
          "id": 221043,
          "text": "<p><span style=\"font-size:12.0pt;\">RNA Polymerase</span></p>"
        },
        {
          "id": 221044,
          "text": "<p><span style=\"font-size:12.0pt;\">Dihydrofolate reductase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate acts by inhibiting: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2058220",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269470,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Dihydrofolate reductase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methotrexate is a chemotherapy agent and immune system suppressant. It acts by inhibiting the enzyme dihydrofolate reductase. This enzyme is crucial for the conversion of dihydrofolate to tetrahydrofolate, a form of folic acid that is required for the synthesis of thymidylate, purines, and the amino acid methionine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">By inhibiting dihydrofolate reductase, methotrexate effectively depletes the cell’s supply of tetrahydrofolate, which in turn inhibits DNA, RNA, and protein synthesis. This inhibition is particularly effective against rapidly dividing cells, which is why methotrexate is used in the treatment of certain cancers and autoimmune diseases.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/whatsapp-image-2024-08-30-at-95817-am.jpeg\" alt=\"\" width=\"500\" height=\"724\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thymidylate synthetase:</strong> Thymidylate synthetase is an enzyme involved in the synthesis of thymidylate (dTMP) from deoxyuridylate (dUMP), which is necessary for DNA synthesis. This enzyme is inhibited by 5-Fluorouracil, not methotrexate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. DNA polymerase:</strong> DNA polymerase is an enzyme responsible for forming new copies of DNA, but methotrexate does not directly inhibit this enzyme. Inhibition of DNA polymerase would prevent DNA replication, but methotrexate acts upstream in the folate pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. RNA Polymerase:</strong> RNA polymerase is responsible for synthesizing RNA from a DNA template. Methotrexate does not inhibit RNA polymerase; instead, it inhibits the production of necessary components for DNA and RNA synthesis indirectly by depleting tetrahydrofolate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methotrexate acts by inhibiting dihydrofolate reductase, thereby preventing the synthesis of DNA, RNA, and proteins by depleting tetrahydrofolate.</span></p>",
      "correct_choice_id": 221044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6894,
      "choices": [
        {
          "id": 27544,
          "text": "<p><span style=\"font-size:12.0pt;\">Myocardial contractility</span></p>"
        },
        {
          "id": 27545,
          "text": "<p><span style=\"font-size:12.0pt;\">Stroke volume</span></p>"
        },
        {
          "id": 27546,
          "text": "<p><span style=\"font-size:12.0pt;\">Arterial wall compliance</span></p>"
        },
        {
          "id": 27547,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac output</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old patient visits his family practitioner for a yearly examination. On examination, his BP was 190/100 mm Hg. His pulse pressure was 90 mm Hg. What would have decreased resulting in this increase in pulse pressure?(INICET NOV 2020)</span></p>",
      "unique_key": "Q3935257",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269481,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Arterial wall compliance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pulse pressure is the difference between systolic and diastolic blood pressure, and it reflects the compliance (elasticity) of the arterial walls. In this scenario, the patient has a high systolic blood pressure and a normal diastolic blood pressure, resulting in an increased pulse pressure of 90 mm Hg (190 mm Hg - 100 mm Hg = 90 mm Hg).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Arterial wall compliance refers to the ability of the arteries to expand and contract with each heartbeat, which helps maintain a steady blood pressure. Decreased arterial wall compliance leads to increased stiffness of the arteries, which can cause an increase in systolic blood pressure and pulse pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Myocardial contractility:</strong> Incorrect. While myocardial contractility can influence blood pressure, it is not directly related to the increase in pulse pressure in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Stroke volume:</strong> Incorrect. Stroke volume affects cardiac output and overall blood pressure but is not the primary factor in the increase in pulse pressure observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Cardiac output:</strong> Incorrect. Cardiac output can affect overall blood pressure, but the specific increase in pulse pressure in this case is more closely linked to decreased arterial wall compliance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Decreased arterial wall compliance leads to increased stiffness of the arteries, resulting in higher systolic blood pressure and an increased pulse pressure, as observed in the patient.</span></p>",
      "correct_choice_id": 27546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32728,
      "choices": [
        {
          "id": 130762,
          "text": "<p>Vitamin A</p>"
        },
        {
          "id": 130763,
          "text": "<p>B<sub>12</sub></p>"
        },
        {
          "id": 130764,
          "text": "<p>Calcium</p>"
        },
        {
          "id": 130765,
          "text": "<p>Thiamine</p>"
        }
      ],
      "text": "<p>Which of the following supplement is required more for a lactating woman than the pregnant female? (INICET MAY 2021)</p>",
      "unique_key": "Q7067481",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269469,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p>Answer: A. Vitamin A</p><p><br>During lactation, the mother's body requires additional nutrients to support breast milk production, which provides all necessary nutrients for the growing infant. Some nutrient needs increase more during lactation than pregnancy.</p><p>&nbsp;</p><p>Comparison of Nutritional Requirements:</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WHnxkwA.png\" width=\"1052\" height=\"215\"></p><p>Vitamin A:</p><p>Needed for:</p><ul><li>Infant vision development</li><li>Immune function</li><li>Epithelial integrity</li></ul><p>Significantly increased loss through breast milk</p><p>Hence, greater requirement in lactation than pregnancy</p><p>&nbsp;</p><p><strong>Others options:</strong></p><p><br>B12, Calcium, and Thiamine requirements increase only slightly or remain the same.</p><p>Vitamin A shows the most significant increase.</p><p>&nbsp;</p><p><strong>Educational Objective:&nbsp;</strong><br><br>Vitamin A is required more for a lactating woman than a pregnant female. This increased need ensures that there is enough vitamin A in breast milk to support the baby's growth and development, particularly for their immune system and vision.</p>",
      "correct_choice_id": 130762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5898,
      "choices": [
        {
          "id": 23562,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Declare as complete abortion and follow-up in 15 days</span></span></span></p>"
        },
        {
          "id": 23563,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Admit and observe</span></span></span></p>"
        },
        {
          "id": 23564,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnostic laparoscopy</span></span></span></p>"
        },
        {
          "id": 23565,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-up with beta-HCG</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with 6 weeks amenorrhea and a positive pregnancy test came with complaints of lower abdominal pain, moderate bleeding PV. She was hemodynamically stable. On ultrasound, there was no gestational sac in the uterus. Ovaries were normal and no free fluid in the pouch of Douglas. What is the next line of management?&nbsp;</span></span></span>(INICET NOV 2020)</p>",
      "unique_key": "Q4621660",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269485,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Follow-up with beta-HCG</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with symptoms that could indicate either an ectopic pregnancy or an early miscarriage. The absence of a gestational sac in the uterus on ultrasound at 6 weeks&#39; gestation warrants further investigation to determine the location and viability of the pregnancy. The most appropriate next step is to follow up with serial beta-HCG levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ectopic Pregnancy vs. Early Miscarriage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The differential diagnosis includes both ectopic pregnancy and early miscarriage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serial Beta-HCG Measurement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Beta-HCG levels typically double every 48-72 hours in a normal early intrauterine pregnancy. An abnormal rise or plateau in beta-HCG levels may indicate an ectopic pregnancy or a failing pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound Follow-up:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In combination with beta-HCG monitoring, follow-up ultrasounds can help determine if a gestational sac becomes visible in the uterus or elsewhere.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Declare as complete abortion and follow-up in 15 days:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Declaring a complete abortion without further investigation is premature and may miss an ectopic pregnancy, which can have serious complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Admit and observe:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While observation is important, serial beta-HCG levels provide critical information that can guide further management decisions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diagnostic laparoscopy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an invasive procedure and is not the first step in stable patients without definitive evidence of ectopic pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient with 6 weeks of amenorrhea, a positive pregnancy test, and no gestational sac visible on ultrasound, the next step is to follow up with serial beta-HCG levels to differentiate between an early intrauterine pregnancy, an ectopic pregnancy, and a miscarriage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Williams Textbook of obstetrics 24<sup>th </sup>edition pg 356</span></strong></span></span></p>",
      "correct_choice_id": 23565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11312,
      "choices": [
        {
          "id": 45214,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase Aspirin dose</span></span></p>"
        },
        {
          "id": 45215,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase atenolol dose</span></span></p>"
        },
        {
          "id": 45216,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add a Long-Acting Nitrate</span></span></p>"
        },
        {
          "id": 45217,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add P2Y12 receptor inhibitor</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 54-year-old woman presented with chest pain. In an angiogram, her left circumflex artery was found to be stenosed, and a stent was inserted. Her current medications include ASA 75mg OD, atenolol 50mg BID, lovastatin, and lisinopril. What should be done in this scenario?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q1953909",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269461,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Add P2Y12 receptor inhibitor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After stent placement, it is crucial to prevent stent thrombosis, which can be life-threatening. Dual antiplatelet therapy (DAPT) is the standard of care in this scenario. DAPT includes aspirin and a P2Y12 receptor inhibitor (such as clopidogrel, prasugrel, or ticagrelor). These medications work synergistically to inhibit platelet aggregation and prevent thrombus formation within the stent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is already on aspirin 75 mg daily, so the addition of a P2Y12 receptor inhibitor is necessary to complete the DAPT regimen. This combination has been shown to significantly reduce the risk of stent thrombosis and other cardiovascular events after percutaneous coronary intervention (PCI) with stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Guidelines on the duration of dual antiplatelet therapy (DAPT) &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug-Eluting Stents (DES)</span></strong><span style=\"font-size:12.0pt\">: A minimum of 6 months of DAPT is recommended. This therapy usually involves the use of aspirin combined with a P2Y12 receptor inhibitor (such as clopidogrel, ticagrelor, or prasugrel) to prevent clot formation around the new stent.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bare Metal Stents (BMS)</span></strong><span style=\"font-size:12.0pt\">: At least 1 month of DAPT is required. Although the duration is shorter than that for DES, it&#39;s crucial for preventing early stent thrombosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Stents Inserted for Acute Coronary Syndrome (ACS)</span></strong><span style=\"font-size:12.0pt\">: If a stent is inserted as part of treatment for ACS, the recommended minimum duration of DAPT extends to 12 months. This extended period helps manage the higher risk of thrombosis and other complications associated with ACS.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Current Patient Situation</span></strong><span style=\"font-size:12.0pt\">: <strong>Ongoing Medication</strong>: The patient is already on aspirin. A P2Y12 receptor inhibitor needs to be added to the regimen to complete the DAPT, ensuring optimal protection against clotting.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increase Aspirin dose:</span></strong><span style=\"font-size:12.0pt\"> Increasing the aspirin dose does not provide additional benefit in preventing stent thrombosis and is not recommended as part of DAPT. The current dose of 75 mg is adequate when combined with a P2Y12 receptor inhibitor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increase atenolol dose:</span></strong><span style=\"font-size:12.0pt\"> Atenolol, a beta-blocker, is used for managing hypertension and angina but does not prevent stent thrombosis. Increasing its dose does not address the immediate need for antiplatelet therapy post-stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Add a Long-Acting Nitrate:</span></strong><span style=\"font-size:12.0pt\"> Long-acting nitrates can help manage angina symptoms but do not prevent stent thrombosis. They are not part of the recommended therapy to prevent thrombotic complications after stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After stent placement, dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor (such as clopidogrel, prasugrel, or ticagrelor) is essential to prevent stent thrombosis and ensure optimal patient outcomes.</span></span></p>",
      "correct_choice_id": 45217,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54779,
      "choices": [
        {
          "id": 218581,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cabergoline</span></span></p>"
        },
        {
          "id": 218582,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></p>"
        },
        {
          "id": 218583,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ergot alkaloids</span></span></p>"
        },
        {
          "id": 218584,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Misoprostol</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following delivery of a preterm baby, the baby died in the NICU despite all efforts. What medication would be given to the mother for reducing breast tenderness? (INICET MAY 2024)</span></span></p>",
      "unique_key": "Q1395830",
      "question_audio": null,
      "question_video": null,
      "map_id": 21269482,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Cabergoline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cabergoline</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a dopamine agonist and is the drug of choice for suppressing lactation. It works by inhibiting prolactin secretion from the pituitary gland, which reduces milk production and alleviates breast engorgement and tenderness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cabergoline is preferred because it is effective, has a favorable side effect profile, and is well-tolerated by most patients. It is also used in conditions like galactorrhea where suppression of lactation is desired.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Dopamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While dopamine agonists like cabergoline work to suppress prolactin, dopamine itself is not used directly for this purpose in clinical settings. Cabergoline, being a dopamine agonist, is more specifically tailored for this function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Ergot alkaloids</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ergot alkaloids have some dopamine agonist activity and can suppress prolactin, but they are not the drug of choice for lactation suppression due to their side effects and less favorable risk profile compared to cabergoline.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Misoprostol</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Misoprostol is a prostaglandin analog used to prevent gastric ulcers, induce labor, and manage postpartum hemorrhage, but it has no role in lactation suppression or reducing breast tenderness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cabergoline is the preferred medication for suppressing lactation and reducing breast tenderness in cases where breastfeeding is not desired or possible, such as after neonatal death</span></span></span></p>",
      "correct_choice_id": 218581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}